Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples